+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
From
Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Biologics Market Report 2025-2035 - Product Thumbnail Image

Biologics Market Report 2025-2035

  • Report
  • March 2025
  • 367 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market Report 2025 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Colorectal Cancer Drugs Market Report 2025 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Acne Drugs Market Report 2025 - Product Thumbnail Image

Acne Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator